Med-tech firms raising money in public or private financings, including: Advanced Oncotherapy, Axis Spine Technologies, Ossio, Prenuvo, Ra Medical Systems, Viome Life Sciences.

Biopharmas raising money in public or private financings, including: Acrivon, Anokion, Avacta, Dice, Digitalis, Empyrean, Tradeup Acquisition, Vectivbio, Xentria.

Med-tech firms raising money in public or private financings, including: Eyenuk, Neuroflow, Surmodics.

Biopharmas raising money in public or private financings, including: Inversago, Oculis, Surge, Treeline, Verona.

PT Etana Biotechnologies Indonesia secured a series B financing of undisclosed value, led by Chinese investors that include Jack Ma’s Yunfeng Capital and Highlight Capital. The funds will be used to strengthen the company's pipeline and to expand its local manufacturing capacity.

Mablink Bioscience SAS raised €31 million (US$30.3 million) in a series A funding round and set its sights on a phase I trial of its lead next-generation antibody-drug conjugate (ADC), MBK-103, which is in development for a range of solid tumor indications. Sofinnova Partners and Mérieux Equity Partners co-led the round.

Biopharmas raising money in public or private financings, including: Prime, Sen-Jam.

Shenzhen Proxinse Medical Technology Co. Ltd. raised an undisclosed amount in a series A financing to develop endoscope-related products. This round of financing was led by Guangdong Technology Financial Group Co. Ltd.

Med-tech firms raising money in public or private financings, including: Bone Biologics.